Hybrid Calcium Phosphate-Polymeric Micelles Incorporating Gadolinium Chelates for Imaging-Guided Gadolinium Neutron Capture Tumor Therapy
Citations Over TimeTop 1% of 2015 papers
Abstract
Gadolinium (Gd) chelates-loaded nanocarriers have high potential for achieving magnetic resonance imaging (MRI)-guided Gd neutron capture therapy (GdNCT) of tumors. Herein, we developed calcium phosphate micelles hybridized with PEG-polyanion block copolymers, and incorporated with the clinical MRI contrast agent Gd-diethylenetriaminepentaacetic acid (Gd-DTPA/CaP). The Gd-DTPA/CaP were nontoxic to cancer cells at the concentration of 100 μM based on Gd-DTPA, while over 50% of the cancer cells were killed by thermal neutron irradiation at this concentration. Moreover, the Gd-DTPA/CaP showed a dramatically increased accumulation of Gd-DTPA in tumors, leading to the selective contrast enhancement of tumor tissues for precise tumor location by MRI. The enhanced tumor-to-blood distribution ratio of Gd-DTPA/CaP resulted in the effective suppression of tumor growth without loss of body weight, indicating the potential of Gd-DTPA/CaP for safe cancer treatment.
Related Papers
- → Gadolinium DTPA‐Monoamide Complexes Incorporated into Mixed Micelles as Possible MRI Contrast Agents(2004)62 cited
- → Design and synthesis of novel DOTA(Gd3+)–polymer conjugates as potential MRI contrast agents(2011)31 cited
- → Block Copolymer-Based Gadolinium Nanoparticles as MRI Contrast Agents with High T 1 Relaxivity(2012)21 cited
- → A self-assembly heterotrinuclear gadolinium(III)–iron(II) complex as a MRI contrast agent(2011)13 cited
- Relaxivities of Gadolinium Heteropoly Complexes in Aqueous Solution for MRI Contrast Agent(2000)